Chronological Change of the Serum IgA/C3 Ratio Indicates the Efficacy ofTonsillectomy for IgA Nephropathy

Background/aims: Although the serum IgA/C3 ratio is a good biomarker to predict the diagnosis, histological findings, and prognosis of IgA nephropathy (IgAN), the chronological change of the IgA/C3 ratio has not been discussed. The present study evaluates the chronological change of the IgA/C3 ratio. Methods: The serum IgA/C3 ratio of 43 IgAN patients was measured at the time of biopsy and on the nearest consultation day in an outpatient clinic since April 30th, 2014. The change rate of the serum IgA/C3 ratio (�IgA/C3/ year) was calculated. The correlation between �IgA/C3/year and other parameters, including the change rate of serum creatinine (�Cr/year), clinical and histological grades, and the risk stratification for end-stage kidney disease (ESKD) in IgAN patients determined by Japanese Society of Nephrology (JSN). Results: The patients with tonsillectomy had a smaller �IgA/C3/year than those without tonsillectomy. �IgA/C3/ year was positively correlated with �Cr/year. �IgA/C3/year decreased along with the severity of histological grade, clinical grade, and ESKD risk. The patients with a combination of tonsillectomy and steroid pulse therapy show a strong down-regulation of �IgA/C3/year and conserved their renal function. A multiple regression analysis revealed that significant enhancers for �IgA/C3/year are tonsillectomy and ESKD risk grade 3, and that those for �Cr/year are tonsillectomy, steroid therapy, and the clinical grade. Conclusion: The serum IgA/C3 ratio does not only show the activity of IgAN, but also the chronological change of the IgA/C3 ratio indicates the efficacy of tonsillectomy for IgAN patients.

[1]  M. Daha,et al.  Role of complement in IgA nephropathy , 2015, Journal of Nephrology.

[2]  T. Hasegawa,et al.  Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy , 2015, Clinical and Experimental Nephrology.

[3]  Yusuke Suzuki,et al.  Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy , 2014, BMC Nephrology.

[4]  Yusuke Suzuki,et al.  A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases , 2014, PloS one.

[5]  Yusuke Suzuki,et al.  A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  Yusuke Suzuki,et al.  A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. , 2013, Journal of nephrology.

[7]  B. Julian,et al.  Pathogenesis of immunoglobulin A nephropathy , 2013, Current opinion in nephrology and hypertension.

[8]  Yusuke Suzuki,et al.  Nationwide survey on current treatments for IgA nephropathy in Japan , 2013, Clinical and Experimental Nephrology.

[9]  Jun Zhang,et al.  Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy , 2013, Nephrology.

[10]  B. Julian,et al.  The pathophysiology of IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[11]  Yusuke Suzuki,et al.  Pathological Role of Tonsillar B Cells in IgA Nephropathy , 2011, Clinical & developmental immunology.

[12]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  R Nair,et al.  Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? , 2006, Kidney international.

[14]  T. Eto,et al.  Relationship between serum IgA/C3 ratio and progression of IgA nephropathy. , 2004, Internal medicine.

[15]  I. Narita,et al.  The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. , 2003, Kidney international.

[16]  Y. Tomino,et al.  Serum IgA/C3 Ratio May Predict Diagnosis and Prognostic Grading in Patients with IgA Nephropathy , 2002, Nephron.

[17]  Y. Taguma,et al.  Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  G. D'Amico,et al.  The commonest glomerulonephritis in the world: IgA nephropathy. , 1987, The Quarterly journal of medicine.

[19]  A. Rifai,et al.  Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA. , 1985, Clinical and experimental immunology.

[20]  M. Endoh,et al.  Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. , 1982, Clinical and experimental immunology.

[21]  J. Egido,et al.  Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. , 1982, Clinical and experimental immunology.

[22]  J. Egido,et al.  IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. , 1980, Clinical and experimental immunology.

[23]  J. Berger,et al.  [Intercapillary deposits of IgA-IgG]. , 1968, Journal d'urologie et de nephrologie.

[24]  M. Mizerska-Wasiak,et al.  Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy , 2014, Pediatric Nephrology.

[25]  No author [Clinical guides for immunoglobulin A (IgA) nephropathy in Japan, third version]. , 2011, Nihon Jinzo Gakkai shi.

[26]  Yusuke Suzuki,et al.  Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models. , 2008, Seminars in nephrology.

[27]  Y. Tomino,et al.  Prediction of diagnosis of immunoglobulin a nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading , 2008, Journal of clinical laboratory analysis.

[28]  Y. Tomino,et al.  Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy , 2003, Journal of clinical laboratory analysis.

[29]  N. Yorioka,et al.  Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy , 2000, Journal of clinical laboratory analysis.

[30]  H. Ohsawa,et al.  Worse urinary findings after stimulating tonsils in patients with IgA nephropathy. , 1994, Nephron.

[31]  P. Zucchelli,et al.  [IgA nephropathy]. , 1985, Medicina clinica.